Application of a novel myristoylproteomics approach identifies GLIPR2 as a key pro-ferroptotic substrate in non-small cell lung cancer
Source abstract
Abstract
Protein myristoylation, catalyzed by N-myristoyltransferases (NMT1 and NMT2), is a key co- and post-translational modification involved in cellular signaling, yet its role in ferroptosis remains poorly defined. Here, we developed a novel myristoylproteomics workflow leveraging click chemistry to comprehensively profile N-myristoylated proteins within NSCLC cells. We found that NMT1 and NMT2 expression positively correlates with ferroptosis sensitivity. Genetic or pharmacological inhibition of NMT attenuated ferroptosis, whereas their overexpression enhanced it. Using our optimized quantitative myristoylproteomics platform, we identified GLIPR2 as a novel myristoylated protein with elevated modification levels in ferroptosis-sensitive cells. Functional studies confirmed that GLIPR2 promotes ferroptosis, and this pro-ferroptotic activity of GLIPR2 requires its N-myristoylation, as a myristoylation-deficient mutant (G2A) failed to restore ferroptosis sensitivity. Our work establishes a robust proteomic methodology for mapping protein myristoylation and uncovers the NMT1/NMT2–GLIPR2 axis as a pivotal regulator of ferroptosis. These findings propose new therapeutic strategies for NSCLC. • Developed and optimized a novel click chemistry-based myristoylproteomics approach for systematic identification of NMT substrates. • Discovered that NMT1/NMT2 expression positively correlates with ferroptosis sensitivity in NSCLC cells. • Screened out GLIPR2 as a new myristoylated protein (higher modification in ferroptosis-sensitive cells) via this technique. • Functional validation showed GLIPR2 exerts pro-ferroptotic effect depending on its myristoylation modification.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ferroptosis and cancer prognosis · Genomics and Chromatin Dynamics · Clusterin in disease pathology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Ferroptosis: an iron-dependent form of nonapoptotic cell death10.1016/j.cell.2012.03.042 ↗
2. Regulation of ferroptotic cancer cell death by GPX410.1016/j.cell.2013.12.010 ↗
3. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer10.1038/s41586-021-03539-7 ↗
4. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis10.1038/s43018-022-00355-4 ↗
5. Inhibition of GPX4 by Toxoplasma gondii promotes ferroptosis and enhances its proliferation in acute and chronic infection10.3390/cells14100756 ↗
6. Ferroptosis: a regulated cell death nexus linking metabolism
7. Emergence of large-scale cell death through ferroptotic trigger waves10.1038/s41586-024-07623-6 ↗
8. PKCbetaII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis10.1038/s41556-021-00818-3 ↗
9. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis10.1016/j.cell.2024.01.030 ↗
10. FSP1 is a glutathione-independent ferroptosis suppressor10.1038/s41586-019-1707-0 ↗
11. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis10.1038/s41586-019-1705-2 ↗
12. A non-canonical vitamin K cycle is a potent ferroptosis suppressor10.1038/s41586-022-05022-3 ↗
13. Regulation of FSP1 myristoylation by NADPH: a novel mechanism for ferroptosis inhibition10.1016/j.redox.2024.103176 ↗
14. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity10.1038/s43018-025-00937-y ↗
15. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma10.7150/thno.55482 ↗
16. The cell biology of ferroptosis10.1038/s41580-024-00703-5 ↗
17. Exploiting ferroptosis vulnerabilities in cancer10.1038/s41556-024-01425-8 ↗
18. Ferroptosis: a flexible constellation of related biochemical mechanisms10.1016/j.molcel.2023.03.005 ↗
19. TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer10.1126/scitranslmed.adk0330 ↗
20. NMT1 and NMT2 are lysine myristoyltransferases regulating the ARF6 GTPase cycle10.1038/s41467-020-14893-x ↗
21. Global profiling of co- and post-translationally N-myristoylated proteomes in human cells10.1038/ncomms5919 ↗
22. Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition10.1186/s12967-024-05150-6 ↗
23. Association of NMT2 with the acyl-CoA carrier ACBD6 protects the N-myristoyltransferase reaction from palmitoyl-CoA10.1194/jlr.M065003 ↗
24. ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability10.1038/s41420-023-01385-2 ↗
25. Phase separation of FSP1 promotes ferroptosis10.1038/s41586-023-06255-6 ↗
26. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer10.1126/scitranslmed.adg3049 ↗
27. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis10.7554/eLife.02523 ↗
28. Activation of lysosomal iron triggers ferroptosis in cancer10.1038/s41586-025-08974-4 ↗
29. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis10.1016/j.chembiol.2023.04.007 ↗
30. Global analysis of N-myristoylation and its heterogeneity by combining N-terminomics and nanographite fluoride-based solid-phase extraction10.1016/j.talanta.2024.126300 ↗
31. Use of alkyne-tagged myristic acid to detect N-terminal myristoylation10.1016/bs.mie.2023.02.019 ↗
32. Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development10.1002/anie.201500342 ↗
33. Correlating chemical sensitivity and basal gene expression reveals mechanism of action10.1038/nchembio.1986 ↗
34. Global profiling of co- and post-translationally N-myristoylated proteomes in human cells10.1038/ncomms5919 ↗
35. Multifunctional reagents for quantitative proteome‐wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development10.1002/anie.201500342 ↗
36. Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen leishmania donovani10.1016/j.chembiol.2015.01.003 ↗
37. Global profiling and inhibition of protein lipidation in vector and host stages of the sleeping sickness parasite trypanosoma brucei10.1021/acsinfecdis.6b00034 ↗
38. Profiling of myristoylation in Toxoplasma gondii reveals an N-myristoylated protein important for host cell penetration10.7554/eLife.57861 ↗
39. Dynamic and reversible aggregation of the human CAP superfamily member GAPR-1 in protein inclusions in Saccharomyces cerevisiae10.1016/j.jmb.2021.167162 ↗
40. Protein lipidation: Occurrence, mechanisms, miological functions, and enabling technologies10.1021/acs.chemrev.6b00750 ↗
41. Identification of a Golgi-localized peptide reveals a minimal Golgi-targeting motif10.1091/mbc.E22-03-0091 ↗
42. N-Myristoytransferase inhibition causes mitochondrial iron overload and parthanatos in TIM17A-Dependent aggressive lung carcinoma10.1158/2767-9764.CRC-23-0428 ↗
43. Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src10.1016/S0021-9258(18)53508-0 ↗
44. Biochemical and structural analysis of N-myristoyltransferase mediated protein tagging10.1016/bs.mie.2023.02.016 ↗
45. Application of liquid-liquid extraction for N-terminal myristoylation proteomics10.1016/j.mcpro.2023.100677 ↗
46. Targeted profiling of Arabidopsis thaliana subproteomes illuminates Co- and posttranslationally N-Terminal myristoylated proteins10.1105/tpc.17.00523 ↗
47. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase10.1074/jbc.M710422200 ↗
48. Intrinsic and extrinsic limitations to the design and optimization of inhibitors of lipid peroxidation and associated cell death10.1021/jacs.2c05252 ↗
49. Sex differences in resilience to ferroptosis underlie sexual dimorphism in kidney injury and repair10.1016/j.celrep.2022.111610 ↗
50. Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP5310.1073/pnas.2009943117 ↗
51. Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response10.1016/j.molcel.2023.08.004 ↗
52. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones10.1016/j.cell.2023.05.003 ↗
53. Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer10.1038/s41467-022-31963-4 ↗
54. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers10.1038/s41467-022-29905-1 ↗
55. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications10.1016/j.cell.2022.06.003 ↗